Earnings Feed
Start Free
Home/Filings/4/0001209191-14-001635
4//SEC Filing

SANTARUS INC 4

Accession 0001209191-14-001635

CIK 0001172480operating
View on SEC.govCompany Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 1:57 PM ET

Size

66.6 KB

Accession

0001209191-14-001635

Insider Transaction Report

Form 4
Period: 2014-01-02
SANTARUS INCSNTS
Ballard E David II
Sr. VP, Clin Res & Med Affairs
Transactions
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$24.51/sh−25,000$612,750→ 0 total
    Exercise: $7.49Exp: 2016-03-01→ Common Stock (25,000 underlying)
  • Award

    Common Stock

    2014-01-02$3.33/sh+8,641$28,775→ 106,854 total
  • Award

    Common Stock

    2014-01-02$3.33/sh+4,219$14,049→ 111,073 total
  • Award

    Common Stock

    2014-01-02$4.93/sh+4,515$22,259→ 115,588 total
  • Disposition to Issuer

    Common Stock

    2014-01-02$32.00/sh−115,588$3,698,816→ 0 total
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$29.64/sh−20,000$592,800→ 0 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.10/sh−70,000$1,757,000→ 0 total
    Exercise: $6.90Exp: 2017-03-12→ Common Stock (70,000 underlying)
  • Award

    Common Stock

    2014-01-02$4.63/sh+37,616$174,162→ 98,213 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−4,515→ 62,985 total
    Exercise: $4.93Exp: 2022-03-12→ Common Stock (4,515 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$28.67/sh−63,281$1,814,266→ 0 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (63,281 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−8,641→ 43,684 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (8,641 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$28.67/sh−43,684$1,252,420→ 0 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (43,684 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−30,471→ 67,029 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (30,471 underlying)
  • Award

    Common Stock

    2014-01-02$2.36/sh+30,471$71,912→ 49,525 total
  • Award

    Common Stock

    2014-01-02$2.30/sh+11,072$25,466→ 60,597 total
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$27.07/sh−62,985$1,705,004→ 0 total
    Exercise: $4.93Exp: 2022-03-12→ Common Stock (62,985 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−4,219→ 63,281 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (4,219 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$16.58/sh−112,500$1,865,250→ 0 total
    Exercise: $15.42Exp: 2023-03-11→ Common Stock (112,500 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−37,616→ 83,040 total
    Exercise: $4.63Exp: 2020-03-10→ Common Stock (37,616 underlying)
  • Award

    Common Stock

    2014-01-02$10.99/sh+9,099$99,998→ 9,099 total
  • Award

    Common Stock

    2014-01-02$6.38/sh+9,955$63,513→ 19,054 total
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$29.70/sh−13,928$413,662→ 0 total
    Exercise: $2.30Exp: 2018-11-14→ Common Stock (13,928 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.62/sh−3,545$90,823→ 0 total
    Exercise: $6.38Exp: 2015-09-21→ Common Stock (3,545 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$24.85/sh−20,412$507,238→ 0 total
    Exercise: $7.15Exp: 2015-02-15→ Common Stock (20,412 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$27.37/sh−83,040$2,272,805→ 0 total
    Exercise: $4.63Exp: 2020-03-10→ Common Stock (83,040 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−11,072→ 13,928 total
    Exercise: $2.30Exp: 2018-11-14→ Common Stock (11,072 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−9,955→ 3,545 total
    Exercise: $6.38Exp: 2015-09-21→ Common Stock (9,955 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.21/sh−24,300$612,603→ 0 total
    Exercise: $6.79Exp: 2016-02-09→ Common Stock (24,300 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−9,099→ 45,901 total
    Exercise: $10.99Exp: 2014-03-19→ Common Stock (9,099 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$21.01/sh−45,901$964,380→ 0 total
    Exercise: $10.99Exp: 2014-03-19→ Common Stock (45,901 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$29.64/sh−67,029$1,986,740→ 0 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (67,029 underlying)
Footnotes (3)
  • [F1]Reflects shares of Santarus, Inc. ("Santarus") common stock, par value $0.0001 per share (the "Shares"), acquired in connection with the exercise of stock options effective and contingent upon the closing of the cash tender offer by Willow Acquisition Sub Corporation ("Merger Sub"), an indirect wholly owned subsidiary of Salix Pharmaceuticals, Ltd. ("Salix"), to purchase all of the issued and outstanding Shares at a purchase price of $32.00 per Share (the "Offer Price"), net to the seller in cash, without interest thereon and subject to any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated December 3, 2013, and in the related letter of transmittal (collectively, as each may be amended or supplemented from time to time, the "Offer").
  • [F2]Reflects stock options to purchase Shares. In connection with the merger (the "Merger") of Merger Sub with and into Santarus pursuant to the Agreement and Plan of Merger, dated as of November 7, 2013 (the "Merger Agreement"), among Salix, Salix Pharmaceuticals, Inc., Merger Sub and Santarus, such stock options (i) became fully vested and exercisable prior to the effective time of the Merger and (ii) to the extent not exercised on or prior to the effective time, were cancelled and converted into the right to receive a cash payment in the amount by which the Offer Price exceeded the exercise price of the stock option as of the effective time of the Merger.
  • [F3]Reflects stock options exercised effective and contingent upon the closing of the Offer.

Documents

1 file

Issuer

SANTARUS INC

CIK 0001172480

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001172480

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 1:57 PM ET
Size
66.6 KB
View on SEC.gov